$OPK
OPKO HEALTH, INC.

2014 Q2 Form 10-Q Financial Statement

#000094480914000011 Filed on August 11, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $23.55M $23.82M
YoY Change -1.16% 133.29%
Cost Of Revenue $12.57M $13.10M
YoY Change -4.11% 99.92%
Gross Profit $10.98M $41.81M
YoY Change -73.74% 113.81%
Gross Profit Margin 46.63% 175.5%
Selling, General & Admin $14.87M $13.88M
YoY Change 7.17% 155.36%
% of Gross Profit 135.46% 33.2%
Research & Development $16.23M $9.557M
YoY Change 69.87% 112.85%
% of Gross Profit 147.85% 22.86%
Depreciation & Amortization $4.027M $3.451M
YoY Change 16.69% 40.63%
% of Gross Profit 36.68% 8.25%
Operating Expenses $58.43M $41.81M
YoY Change 39.77% 113.81%
Operating Profit -$34.89M -$17.98M
YoY Change 93.99% 75.55%
Interest Expense $6.300M $8.900M
YoY Change -29.21% -4550.0%
% of Operating Profit
Other Income/Expense, Net $9.279M $16.93M
YoY Change -45.18% -6463.16%
Pretax Income -$25.61M -$1.057M
YoY Change 2322.52% -89.18%
Income Tax $101.0K $925.0K
% Of Pretax Income
Net Earnings -$25.48M -$3.394M
YoY Change 650.74% -66.87%
Net Earnings / Revenue -108.22% -14.25%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.08 -$10.10K
COMMON SHARES
Basic Shares Outstanding 413.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $134.0M $169.1M
YoY Change -20.76% 205.79%
Cash & Equivalents $134.0M $119.1M
Short-Term Investments $50.00M
Other Short-Term Assets $2.613M $19.00M
YoY Change -86.25% 363.41%
Inventory $18.33M $19.78M
Prepaid Expenses
Receivables $23.11M $22.23M
Other Receivables $1.900M $0.00
Total Short-Term Assets $183.0M $230.1M
YoY Change -20.47% 149.31%
LONG-TERM ASSETS
Property, Plant & Equipment $17.35M $16.58M
YoY Change 4.65% 218.79%
Goodwill $226.0M $82.09M
YoY Change 175.32%
Intangibles $79.78M
YoY Change
Long-Term Investments $27.40M $26.70M
YoY Change 2.62% 80.41%
Other Assets $4.910M $2.784M
YoY Change 76.36% 132.0%
Total Long-Term Assets $1.144B $411.0M
YoY Change 178.39% 197.37%
TOTAL ASSETS
Total Short-Term Assets $183.0M $230.1M
Total Long-Term Assets $1.144B $411.0M
Total Assets $1.327B $641.1M
YoY Change 107.01% 178.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.04M $11.65M
YoY Change -13.78% 164.68%
Accrued Expenses $54.96M $31.05M
YoY Change 77.05% 144.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $14.40M $16.78M
YoY Change -14.19% 14.92%
Total Short-Term Liabilities $79.40M $59.47M
YoY Change 33.52% 87.6%
LONG-TERM LIABILITIES
Long-Term Debt $2.948M $188.5M
YoY Change -98.44%
Other Long-Term Liabilities $218.5M $80.60M
YoY Change 171.07% 426.82%
Total Long-Term Liabilities $334.9M $269.1M
YoY Change 24.42% 1659.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $79.40M $59.47M
Total Long-Term Liabilities $334.9M $269.1M
Total Liabilities $414.3M $328.6M
YoY Change 26.07% 501.82%
SHAREHOLDERS EQUITY
Retained Earnings -$573.2M -$426.4M
YoY Change 34.44%
Common Stock $4.271M $3.391M
YoY Change 25.95%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.051M $7.457M
YoY Change -45.68%
Treasury Stock Shares 1.245M shares 2.293M shares
Shareholders Equity $917.4M $314.5M
YoY Change
Total Liabilities & Shareholders Equity $1.327B $641.1M
YoY Change 107.01% 178.13%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$25.48M -$3.394M
YoY Change 650.74% -66.87%
Depreciation, Depletion And Amortization $4.027M $3.451M
YoY Change 16.69% 40.63%
Cash From Operating Activities -$21.90M -$6.000M
YoY Change 265.0% -4.76%
INVESTING ACTIVITIES
Capital Expenditures -$1.600M -$1.300M
YoY Change 23.08% 550.0%
Acquisitions
YoY Change
Other Investing Activities -$1.500M -$51.90M
YoY Change -97.11% 1106.98%
Cash From Investing Activities -$3.000M -$53.20M
YoY Change -94.36% 1082.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.500M -3.300M
YoY Change -175.76% -273.68%
NET CHANGE
Cash From Operating Activities -21.90M -6.000M
Cash From Investing Activities -3.000M -53.20M
Cash From Financing Activities 2.500M -3.300M
Net Change In Cash -22.40M -62.50M
YoY Change -64.16% 602.25%
FREE CASH FLOW
Cash From Operating Activities -$21.90M -$6.000M
Capital Expenditures -$1.600M -$1.300M
Free Cash Flow -$20.30M -$4.700M
YoY Change 331.91% -22.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1985000 USD
CY2014Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
619000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13414000 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10041000 USD
CY2013Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
21652000 USD
CY2014Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
24660000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23113000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19767000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4399000 USD
CY2014Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
5405000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
402000 USD
CY2014Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1320000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3418000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
702000 USD
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
406000 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
54964000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65874000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
304000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1379383000 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1490071000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1885000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1547000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
343000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1807000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2688000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5402000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5569000 USD
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2826000 USD
CY2013Q4 us-gaap Assets
Assets
1391516000 USD
CY2014Q2 us-gaap Assets
Assets
1327082000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
183010000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
242728000 USD
CY2014Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
9883000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
12062000 USD
CY2014Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
4745000 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
4301000 USD
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
1300000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1652000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2572000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-71163000 USD
CY2014Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-26077000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-51809000 USD
CY2013Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-14238000 USD
CY2014Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
23545000 USD
CY2013Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
23821000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
55197000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
45818000 USD
CY2014Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1876000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4486000 USD
CY2013Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2577000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
3921000 USD
CY2013Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
71600000 USD
CY2014Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
72900000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185798000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134010000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119061000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27361000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-51788000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
91700000 USD
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7130000 USD
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
414818195 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
427102876 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
4148000 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
4271000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42555000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73140000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26575000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8657000 USD
CY2013Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
211912000 USD
CY2014Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
116365000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13103000 USD
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12565000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24955000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24860000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-602000 USD
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
8300000 USD
CY2014Q2 us-gaap Deferred Revenue
DeferredRevenue
8300000 USD
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6393000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7639000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
166435000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
165226000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6880000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7591000 USD
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4027000 USD
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3451000 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-106000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
85000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.3847
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
800000 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
131400000 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
17700000 USD
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
25200000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
29625000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24403000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
74533000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-450000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
69059000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
824000 USD
CY2013Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
12651000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
452000 USD
CY2014Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
10967000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-10898000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
10821000 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
1274000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2668000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2014Q2 us-gaap Goodwill
Goodwill
226001000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
226373000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Other Changes
GoodwillOtherChanges
-372000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25606000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1057000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-68023000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-31886000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-26077000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-71163000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-39115000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4353000 USD
CY2014Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-370000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2426000 USD
CY2013Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2371000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6261000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
925000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
101000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
714000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
968000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
242000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
796000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3308000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
333000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4321000 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
420000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3663000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1213000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1413000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-97000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3911000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3324000 USD
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
793341000 USD
CY2014Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
793326000 USD
us-gaap Interest Paid
InterestPaid
318000 USD
us-gaap Interest Paid
InterestPaid
2771000 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12455000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13374000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
18334000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
18079000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4132000 USD
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4948000 USD
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
777000 USD
CY2014Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
579000 USD
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
1510000 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1350000 USD
us-gaap Inventory Write Down
InventoryWriteDown
583000 USD
us-gaap Inventory Write Down
InventoryWriteDown
1273000 USD
CY2014Q2 us-gaap Liabilities
Liabilities
414257000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
518537000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1391516000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1327082000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91850000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
79402000 USD
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
426687000 USD
CY2014Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
334855000 USD
CY2013Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
9061000 USD
CY2014Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
9544000 USD
CY2014Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
14346000 USD
CY2014Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
14397000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12562000 USD
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2948000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3270000 USD
CY2014Q2 us-gaap Long Term Investments
LongTermInvestments
33428000 USD
CY2013Q4 us-gaap Long Term Investments
LongTermInvestments
30653000 USD
CY2014Q2 us-gaap Minority Interest
MinorityInterest
-4567000 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
-3431000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4001000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
163785000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53848000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3331000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-44541000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18131000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-3394000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37609000 USD
us-gaap Net Income Loss
NetIncomeLoss
-70026000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-25480000 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-959000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1506000 USD
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-597000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1137000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25480000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3394000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70026000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38029000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16926000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9279000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7130000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2863000 USD
CY2013Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6151000 USD
CY2014Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
0 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
58430000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
41804000 USD
us-gaap Operating Expenses
OperatingExpenses
79953000 USD
us-gaap Operating Expenses
OperatingExpenses
110978000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17983000 USD
dei Document Type
DocumentType
10-Q
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34885000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-65160000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-24756000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15878000 USD
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14206000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5653000 USD
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2613000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4910000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6861000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-2561000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2085000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1762000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
188000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1613000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3114000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
900000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
4593000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
3602000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
553000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
424000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1829000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-948000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1283000 USD
CY2013Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
1509000 USD
CY2014Q2 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
2020000 USD
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
218490000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
214775000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10358000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4808000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8027000 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2990000 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
0 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
6264000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
3557000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
3120000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
6435000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
2539000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1331000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-11496000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
3015000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-78000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1695000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
500000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
13341000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
50027000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2054000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2467000 USD
CY2014Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2013Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7553000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19084000 USD
CY2013Q4 us-gaap Prepaid Insurance
PrepaidInsurance
892000 USD
CY2014Q2 us-gaap Prepaid Insurance
PrepaidInsurance
1113000 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications of certain amounts. </font><font style="font-family:inherit;font-size:10pt;">During 2013 and the first quarter of 2014, we reported payments for contingent consideration and some deferred payments as cash outflows from operating activities. Amounts paid pertaining to the initial purchase accounting contingent liability have been classified as cash outflows from financing activities, reflecting such payments as financing is more accurate, thus, the change in accounting policy. Amounts paid in excess of the purchase accounting contingent liability have been classified as cash outflows from operating activities. We have adjusted the amounts previously reported in our Form 10-Q for the </font><font style="font-family:inherit;font-size:10pt;">six months ended June 30, 2013</font><font style="font-family:inherit;font-size:10pt;"> in conjunction with the filing of this Form10-Q and the </font><font style="font-family:inherit;font-size:10pt;">six months ended June 30, 2014</font><font style="font-family:inherit;font-size:10pt;"> by reducing cash outflows from operating activities&#160;and increasing cash outflows from financing activities by&#160;</font><font style="font-family:inherit;font-size:10pt;">$6.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> for 2014 and 2013, respectively. </font></div></div>
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
170184000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1519000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2747000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15354000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
14258000 USD
us-gaap Profit Loss
ProfitLoss
-39115000 USD
us-gaap Profit Loss
ProfitLoss
-71163000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17348000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17027000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
329000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-68000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
553000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
17718000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
14571000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19467000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9557000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16234000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37227000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2013Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2014Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10055000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10055000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-573203000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-503177000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
18618000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
34145000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
41219000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
21392000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
23545000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
23821000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
55197000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
45818000 USD
CY2014Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
2153000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
4123000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6280000 USD
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
3188000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14874000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28686000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13879000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26303000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7003000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6993000 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3400000 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1800000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
876410000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
917392000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
872979000 USD
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
912825000 USD
CY2013Q4 us-gaap Supplies
Supplies
945000 USD
CY2014Q2 us-gaap Supplies
Supplies
1910000 USD
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1245367 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2264063 shares
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
7362000 USD
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
4051000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>
CY2014Q2 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
7700000 USD
CY2013Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
6700000 USD
CY2014Q2 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
13500000 USD
CY2013Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
10400000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
324898133 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
413125932 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
336732215 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
413339679 shares
CY2014Q2 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
2616000 USD
CY2013Q4 opk Accrued Clinical Trials Current
AccruedClinicalTrialsCurrent
3342000 USD
CY2014Q2 opk Accumulated Income Loss From Equity Method Investments
AccumulatedIncomeLossFromEquityMethodInvestments
18696000 USD
CY2014Q2 opk Available For Sale Securities Gross Unrealized And Realized Gain Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedAndRealizedGainLossAccumulatedInInvestments
8827000 USD
CY2014Q2 opk Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
2675000 USD
CY2013Q4 opk Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
3739000 USD
CY2014Q2 opk Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
517000 USD
CY2013Q4 opk Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
0 USD
CY2014Q2 opk Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net
AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet
2980000 USD
CY2013Q4 opk Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net
AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet
4022000 USD
CY2014Q2 opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.06
opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.17
opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.13
CY2013Q2 opk Business Acquisition Pro Forma Earnings Per Share Basicand Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted
-0.03
CY2014Q2 opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-25480000 USD
CY2013Q2 opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-13279000 USD
opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-70026000 USD
opk Business Acquisition Pro Forma Net Income Loss Availableto Common Stockholders
BusinessAcquisitionProFormaNetIncomeLossAvailabletoCommonStockholders
-50303000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Discount Rates Increase One Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfDiscountRatesIncreaseOnePercent
2100000 USD
opk Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent
700000 USD
CY2014Q2 opk Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
24618000 USD
CY2013Q4 opk Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
28047000 USD
CY2014Q2 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
0 USD
CY2013Q4 opk Business Combination Deferred Acquisition Payments Netof Discount Current
BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent
5465000 USD
CY2013Q4 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
1100000000 USD
CY2014Q2 opk Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets
1100000000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
815000 USD
opk Common Stock Warrants Net Exercised
CommonStockWarrantsNetExercised
3493000 USD
CY2013Q4 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
14 institution
CY2014Q2 opk Debt Instruments Numberof Financial Institutions
DebtInstrumentsNumberofFinancialInstitutions
12 institution
CY2013Q2 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-1982000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-32854000 USD
opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-68737000 USD
CY2014Q2 opk Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax
IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax
-25707000 USD
CY2013Q2 opk Interest Expense Nonoperating
InterestExpenseNonoperating
3842000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
8171000 USD
opk Interest Expense Nonoperating
InterestExpenseNonoperating
6739000 USD
CY2014Q2 opk Interest Expense Nonoperating
InterestExpenseNonoperating
4685000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
48000 USD
opk Interest Income Nonoperating
InterestIncomeNonoperating
149000 USD
CY2013Q2 opk Interest Income Nonoperating
InterestIncomeNonoperating
90000 USD
CY2014Q2 opk Interest Income Nonoperating
InterestIncomeNonoperating
7000 USD
CY2012Q3 opk Numberof Medicare Claims Includedin Post Payment Review Audit
NumberofMedicareClaimsIncludedinPostPaymentReviewAudit
183 claim
opk Percentage Of Increase Decrease In Discount Rate
PercentageOfIncreaseDecreaseInDiscountRate
0.01
CY2014Q2 opk Percentage Of Increase Decrease In Future Sales
PercentageOfIncreaseDecreaseInFutureSales
0.10
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
120000 USD
opk Revenue From Receipt Of Equity
RevenueFromReceiptOfEquity
12620000 USD
opk Revenue From Sale Of Intellectual Property
RevenueFromSaleOfIntellectualProperty
0 USD
opk Revenue From Sale Of Intellectual Property
RevenueFromSaleOfIntellectualProperty
12500000 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
14772000 USD
CY2013Q2 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
2015000 USD
CY2014Q2 opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
0 USD
opk Revenue From Transfer Of Intellectual Property
RevenueFromTransferOfIntellectualProperty
476000 USD
CY2014Q2 opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
320417 shares
opk Shares Surrendered In Lieu Of Cash Payment
SharesSurrenderedInLieuOfCashPayment
395156 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
1705406 shares
CY2014Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised
1102741 shares
CY2014Q2 opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
782324 shares
opk Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment
StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment
1310250 shares
CY2013Q4 opk Taxes Recoverable Current
TaxesRecoverableCurrent
3458000 USD
CY2014Q2 opk Taxes Recoverable Current
TaxesRecoverableCurrent
1298000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000944809
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
429195973 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Opko Health, Inc.

Files In Submission

Name View Source Status
0000944809-14-000011-index-headers.html Edgar Link pending
0000944809-14-000011-index.html Edgar Link pending
0000944809-14-000011.txt Edgar Link pending
0000944809-14-000011-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
opk-20140630.xml Edgar Link completed
opk-20140630.xsd Edgar Link pending
opk-20140630_cal.xml Edgar Link unprocessable
opk-20140630_def.xml Edgar Link unprocessable
opk-20140630_lab.xml Edgar Link unprocessable
opk-20140630_pre.xml Edgar Link unprocessable
opk-6302014x10q.htm Edgar Link pending
opk-6302014xex311.htm Edgar Link pending
opk-6302014xex312.htm Edgar Link pending
opk-6302014xex321.htm Edgar Link pending
opk-6302014xex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending